DB18357InvestigationalProtein Based Therapies
T-Guard: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on T-cell surface glycoprotein CD3 and T-cell antigen CD7
Resolves to
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with T-Guard, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account